ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0461

Plasmablast-derived Autoantibodies from Individuals At-risk for RA That Target RA-relevant Antigens Are Polyreactive with Arthritogenic Bacteria

Meagan Chriswell1, Jennifer Seifert2, Michelle Bloom3, Cliff Rims4, Marie Feser5, Kevin Deane6, Jill Norris7, Eddie James8, Jane Buckner9, William Robinson10, V. Michael Holers11 and Kristine Kuhn12, 1UC Denver SOM, Denver, CO, 2University of Colorado School of Medicine, Littleton, CO, 3Stanford University, Redwood City, CA, 4Benaroya Research Institute, Seattle, WA, 5University of Colorado Denver, Aurora, CO, 6University of Colorado Denver, Denver, CO, 7Colorado School of Public Health, Aurora, CO, 8Benaroya Research Institute at Virginia Mason, Monroe, WA, 9Benaroya Research Institute at Virginia Mason, Seattle, WA, 10Stanford University, Palo Alto, CA, 11University of Colorado, Denver, CO, 12University of Colorado Anschutz Medical Campus, Aurora, CO

Meeting: ACR Convergence 2021

Keywords: Anti-citrullinated Protein Autoantibodies (ACPAs), immunology, Mouse Models, RA, prevention, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Abstracts: RA – Etiology & Pathogenesis (0458–0461)

Session Type: Abstract Session

Session Time: 11:15AM-11:30AM

Background/Purpose: Circulating autoantibodies like ACPA frequently develop years before symptoms of RA, during which the individual is at-risk for disease. Several lines of evidence suggest that these autoantibodies may be driven by microbial-mucosal interactions. We hypothesized that discrete gut-derived bacteria drive autoantibody generation.

Methods: Dual IgA/IgG family plasmablasts (n=94) were isolated from 4 individuals at-risk for RA, defined as serum anti-CCP+ (75%) and/or RF+ (75%), and from 2 anti-CCP+ individuals with early RA. Fab domains from the plasmablast-derived mAbs (PB-mAbs), selected for binding of RA-relevant antigens on a protein microarray, were expressed in a mouse IgG2a scaffold. The PB-mAbs were used to identify targeted fecal bacteria, and Ruminococcaceae(Rumino) strains were isolated from the feces of a human at-risk for RA. 16S sequencing identified seven Rumino family strains of interest, and through whole genome sequencing we identified an as yet unnamed species within genus Subdoligranulum (Sbg). Human PBMC were isolated and exposed to individual strains of Sbg to gauge memory responses by assessing in vitro CD154+ upregulation on CD4+ T cells. Germ free DBA/1 mice were colonized with each Sbg strain, as well as Prevotella copri and PBS as controls, and were monitored for stable colonization, autoantibody development, and joint swelling. Serum collected from arthritogenic Sbg monocolonized mice was injected into naive germ-free DBA/1 mice, and mice were monitored for joint swelling.

Results: All PB-mAbs bound RA-relevant antigens and 58/94 (62%) targeted families Lachno(spiraceae)/Rumino from a pool of fecal bacteria (derived from 5 healthy controls, 8 at-risk individuals, and 5 RA cases) at a disproportionately elevated level (56.31 ± 12.85% of all bacteria bound) compared to other taxa, suggesting cross-reactivity between bacterial and host antigens. We verified PB-mAb binding of Lachno/Rumino using our generated Sbg strains. We then observed an MHC class II-dependent memory T cell response in PBMCs against a subset of the Sbg strains in individuals with RA that was nearly absent in controls. To determine if Sbg could induce autoantibodies in vivo, germ-free mice were stably colonized with the Sbg strains, P. copri, or sterile PBS; within 14 days, joint swelling was observed only in mice monocolonized with a subset of the Sbg strains. Joint swelling was associated with an expansion of antibodies to RA-relevant antigens. Transfer of serum from affected Sbg strain colonized mice, but not P. copri or PBS controls, to naïve mice resulted in joint swelling.

Conclusion: A subset of circulating dual IgA/IgG PB-mAbs isolated from individuals at-risk for RA target both RA-relevant antigens and bacteria within families Lachno/Rumino. A specific strain from the genus Sbg established from an at-risk individual were recognized by T cells from RA cases. When germ-free mice were monocolonized with the specific Sbg strain, they developed joint swelling and serum autoantibodies capable of transferring the joint swelling phenotype. Our data suggests one model in which a strain of bacteria is capable of stimulating the development of pathogenic autoantibodies.


Disclosures: M. Chriswell, None; J. Seifert, None; M. Bloom, None; C. Rims, None; M. Feser, None; K. Deane, Inova Diagnostics, Inc, 5, Bristol Meyers Squibb, 1, 5, Janssen Research and Development, LLC, 5, imaware, 2, ThermoFisher, 2, 5, Medscape, 6; J. Norris, None; E. James, Janssen R&D, 5, Pfizer, 5, Novartis, 5, Provention Bio, 1, BMS, 5; J. Buckner, Janssen R&D, 5; W. Robinson, None; V. Holers, Jansson, 5; K. Kuhn, None.

To cite this abstract in AMA style:

Chriswell M, Seifert J, Bloom M, Rims C, Feser M, Deane K, Norris J, James E, Buckner J, Robinson W, Holers V, Kuhn K. Plasmablast-derived Autoantibodies from Individuals At-risk for RA That Target RA-relevant Antigens Are Polyreactive with Arthritogenic Bacteria [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/plasmablast-derived-autoantibodies-from-individuals-at-risk-for-ra-that-target-ra-relevant-antigens-are-polyreactive-with-arthritogenic-bacteria/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/plasmablast-derived-autoantibodies-from-individuals-at-risk-for-ra-that-target-ra-relevant-antigens-are-polyreactive-with-arthritogenic-bacteria/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology